Cancer surveillance in non-alcoholic fatty liver disease: A potential role for lipidomics

Código QR

Cancer surveillance in non-alcoholic fatty liver disease: A potential role for lipidomics

Guardado en:

Detalles Bibliográficos
Autores principales:	Jan Best, Lars P. Bechmann
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/6bf08e17cf1444358d29e712e207ffc9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The Effect of Mycotoxins and Silymarin on Liver Lipidome of Mice with Non-Alcoholic Fatty Liver Disease
por: Kamila Bechynska, et al.
Publicado: (2021)

The Role of Bone Morphogenetic Protein Signaling in Non-Alcoholic Fatty Liver Disease
por: Timothy E. Thayer, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease in polycystic ovary syndrome women
por: Young Bin Won, et al.
Publicado: (2021)

Oxidative stress and cardiometabolic biomarkers in patients with non-alcoholic fatty liver disease
por: Aleksandra Klisic, et al.
Publicado: (2021)

Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease
por: Xiaojiaoyang Li, et al.
Publicado: (2021)

SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease
por: Guillermo Mazzolini, et al.
Publicado: (2018)

Perchlorate exposure does not induce obesity or non-alcoholic fatty liver disease in zebrafish.
por: Michael R Minicozzi, et al.
Publicado: (2021)

Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease
por: Hee Kyung Shin, et al.
Publicado: (2021)

Three-dimensional ultrastructure of giant mitochondria in human non-alcoholic fatty liver disease
por: Gerald J. Shami, et al.
Publicado: (2021)

Hepatic lymphocytes involved in the pathogenesis of pediatric and adult non-alcoholic fatty liver disease
por: Victoria Cairoli, et al.
Publicado: (2021)

Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice.
por: Yvonne Ritze, et al.
Publicado: (2014)

Non-Alcoholic Fatty Liver Disease and Hypothyroidism: Review of Clinical and Experimental Studies
por: Tetiana Ranhulova
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease as a Risk for Colorectal Cancer Development and the Role of Screening Colonoscopy in Clinical Practice
por: Cosmas Rinaldi Adithya Lesmana, et al.
Publicado: (2019)

The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease
por: Hao Xu, et al.
Publicado: (2021)

Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.
por: Giovanni Musso, et al.
Publicado: (2014)

Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
por: Anja Baumann, et al.
Publicado: (2021)

High-fructose feeding does not induce steatosis or non-alcoholic fatty liver disease in pigs
por: Nikolaj H. Schmidt, et al.
Publicado: (2021)

Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndrome
por: Aleksandr I. Pavlov, et al.
Publicado: (2021)

Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease.
por: Samshol Sukahri, et al.
Publicado: (2021)

Author Correction: Perceived stress and non-alcoholic fatty liver disease in apparently healthy men and women
por: Danbee Kang, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice
por: Siân P. Cartland, et al.
Publicado: (2017)

Clinical implications of renin–angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease
por: Kwang Min Kim, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease is an influencing factor for the association of SHBG with metabolic syndrome in diabetes patients
por: Xiaomin Hua, et al.
Publicado: (2017)

Close association between non-alcoholic fatty liver disease and ossification of the posterior longitudinal ligament of the spine
por: Tsutomu Endo, et al.
Publicado: (2021)

Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease
por: Kaitlin Day, et al.
Publicado: (2021)

Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease
por: Yong Jiang, et al.
Publicado: (2017)

PRESENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS OF UNCONTROLLED AND CONTROLLED TYPE 2 DIABETES MELLITUS
por: Aqeela Rashid, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease is associated with bacterial translocation and a higher inflammation response in psoriatic patients
por: Isabel Belinchón-Romero, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes.
por: Giovanni Targher, et al.
Publicado: (2013)

Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
por: Reza Fadaei, et al.
Publicado: (2018)

Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery
por: Andrew Yang, et al.
Publicado: (2021)

Associations between longer habitual day napping and non-alcoholic fatty liver disease in an elderly Chinese population.
por: Hua Qu, et al.
Publicado: (2014)

Role of Ferroptosis in Non-Alcoholic Fatty Liver Disease and Its Implications for Therapeutic Strategies
por: Han Zhang, et al.
Publicado: (2021)

Non-laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: development, validation and comparison with other scores.
por: Yong-ho Lee, et al.
Publicado: (2014)

Tomato lycopene prevention of alcoholic fatty liver disease and hepatocellular carcinoma development
por: Camilla P. Stice, et al.
Publicado: (2018)

The interactive effects of non-alcoholic fatty liver disease and hemoglobin concentration in the first trimester on the development of gestational diabetes mellitus.
por: Mengnan Li, et al.
Publicado: (2021)

Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study.
por: Atul Goyale, et al.
Publicado: (2021)

Serum matrix metalloproteinase 7 (MMP7) is a biomarker of fibrosis in patients with non-alcoholic fatty liver disease
por: Katharine M. Irvine, et al.
Publicado: (2021)

Maternal tadalafil therapy for fetal growth restriction prevents non-alcoholic fatty liver disease and adipocyte hypertrophy in the offspring
por: Takuya Kawamura, et al.
Publicado: (2021)

Risk of Non-Alcoholic Fatty Liver Disease in Xanthelasma Palpebrarum
por: Chen HW, et al.
Publicado: (2021)